| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Vor Biopharma Inc.
13G/A
VOR · 929033207
|
2.0% |
5/6/2026
Event 3/31/2026
|
||||
| Qiming Venture Partners VIII-HC, L.P. | 2.0% | |||||
| Qiming Venture Partners VIII Investments, LLC | 1.7% | |||||
| Qiming GP VIII, LLC | 1.7% | |||||
| Qiming GP VIII-HC, LLC | 2.0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.